2024
Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States
Park H, Gonsalves G, Tan S, Kelly J, Rutherford G, Wachter R, Schechter R, Paltiel A, Lo N. Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States. Nature Communications 2024, 15: 1883. PMID: 38448400, PMCID: PMC10917753, DOI: 10.1038/s41467-024-45549-9.Peer-Reviewed Original ResearchConceptsSevere COVID-19Risk of severe COVID-19COVID-19 booster vaccinationBooster vaccinationHigh-risk populationAbsolute annual riskWaning of protectionImmunocompromised populationsFrequent boostingOlder age groupsAnnual boosterImmune evasionImmunocompromised personsPublic health needsPublic health guidanceRisk groupsFrequent boostersImmune statusRisk factorsFrequency of booster vaccinationHealth needsHealth guidanceCompare frequenciesAge groupsVaccine
2016
Strategies to Prevent Cholera Introduction during International Personnel Deployments: A Computational Modeling Analysis Based on the 2010 Haiti Outbreak
Lewnard JA, Antillón M, Gonsalves G, Miller AM, Ko AI, Pitzer VE. Strategies to Prevent Cholera Introduction during International Personnel Deployments: A Computational Modeling Analysis Based on the 2010 Haiti Outbreak. PLOS Medicine 2016, 13: e1001947. PMID: 26812236, PMCID: PMC4727895, DOI: 10.1371/journal.pmed.1001947.Peer-Reviewed Original ResearchConceptsOral cholera vaccineProbability of casesAntimicrobial chemoprophylaxisCholera vaccineOral cholera vaccinationAntimicrobial regimensProphylactic efficacyAsymptomatic carriageCholera vaccinationAsymptomatic carriersIncidence rateLargest cholera epidemicCholera epidemicChemoprophylaxisCholera incidence ratesFalse-positive test outcomesVaccinationFirst weekDiagnostic screeningAntimicrobial chemotherapyHaiti cholera epidemicIntervention strategiesVaccineIndependent panelCholera importation